The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current earnings are C$33.42 Billion. a decrease over its 2023 earnings that were of C$10.97 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | C$6.44 B | -41.32% |
2023 | C$10.97 B | 6.93% |
2022 | C$10.26 B | 9.63% |
2021 | C$9.36 B | -17.61% |
2020 | C$11.36 B | -11% |
2019 | C$12.76 B | -4.26% |
2018 | C$13.33 B | -0.54% |
2017 | C$13.40 B | 4.74% |
2016 | C$12.80 B | 14.85% |
2015 | C$11.14 B | 42.85% |
2014 | C$7.80 B | 6.08% |
2013 | C$7.35 B | 5.11% |
2012 | C$6.99 B | 20.7% |
2011 | C$5.79 B | -21.95% |
2010 | C$7.42 B | 2.17% |
2009 | C$7.27 B | -0.88% |
2008 | C$7.33 B | 32.54% |
2007 | C$5.53 B | -1.47% |
2006 | C$5.61 B | -17.42% |
2005 | C$6.80 B | 43.39% |
2004 | C$4.74 B | 7% |
2003 | C$4.43 B | -550.38% |
2002 | -C$0.99 Billion | -141.78% |
2001 | C$2.35 B | 0.72% |
2000 | C$2.33 B | 6.9% |
1999 | C$2.18 B | 27.92% |
1998 | C$1.71 B | 42.14% |
1997 | C$1.20 B | -10.49% |
1996 | C$1.34 B | 21.14% |
1995 | C$1.10 B | 34.99% |
1994 | C$0.82 B | -0.66% |
1993 | C$0.82 B | 5.22% |
1992 | C$0.78 B | 256.55% |
1991 | C$0.22 B | 549.79% |
1990 | C$33.95 M | -157.58% |
1989 | -C$58.97 Million | -410.29% |
1988 | C$19 M | -20.47% |
1987 | C$23.89 M | 263.83% |
1986 | C$6.56 M | 487.5% |
1985 | C$1.11 M | -112.7% |
1984 | -C$8.81 Million |